CRP and type 2 diabetes mellitus: Most of the trials with marine LCn3, administered especially as fish oil supplements, have not shown any effect on circulating fasting inflammatory markers in healthy people [13,14], individuals with high risk of developing CVD, or individuals with type 2 diabetes [12], while decreased levels of circulating CRP and IL-6 have been observed in some other studies [15,16].